Increased vincristine neurotoxicity during treatment with itraconazole in 3 pediatric patients with acute myelogenous leukemia.

被引：0
|
作者：
Muenchow, N [1 ]
Janka, G [1 ]
Erttmann, R [1 ]
Looft, G [1 ]
Bielack, S [1 ]
Winkler, K [1 ]
机构：
[1] Univ Hamburg Hosp, Dept Pediat Hematol & Oncol, D-2000 Hamburg, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4253
引用
收藏
页码：234B / 234B
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN OLDER PATIENTS
    FOON, KA
    ZIGHELBOIM, J
    GALE, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (24): : 1470 - 1470
  • [22] Analysis of a targeted receptor tyrosine kinase inhibitor in the treatment of acute myelogenous leukemia.
    Menzel, LP
    Shankar, DB
    Shah, NP
    Hummerickhouse, R
    Hagey, A
    Sakamoto, KM
    Moore, TB
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S105 - S105
  • [23] Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia
    Watt, Tanya C.
    Cooper, Todd
    PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 756 - 757
  • [24] COMPARISON OF POPULATION PHARMACOKINETIC AND PHYSIOLOGIC BASED PHARMACOKINETIC MODELS FOR VINCRISTINE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA.
    Quinney, S. K.
    Chiang, C.
    Li, C. H.
    Li, L.
    Bies, R. R.
    Egbelakin, A.
    Ho, R.
    Hutchinson, R.
    Smith, E. L.
    Wells, E.
    Renbarger, J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S119 - S119
  • [25] The Prevalence of Fanconi Anemia Among Patients with De Novo Acute Myelogenous Leukemia.
    Rochowski, Andrzej
    Rosenberg, Philip S.
    Alonzo, Todd A.
    Gerbing, Robert B.
    Lange, Beverly
    Alter, Blanche P.
    BLOOD, 2010, 116 (21) : 918 - 918
  • [26] Analysis of the PI3/Akt/Survivin Pathway in Acute Myelogenous Leukemia.
    Serrano, Josefina
    Serrano-Lopez, Juana
    Sanchez Garcia, Joaquin
    Herrera, Concepcion
    Torres Gomez, Antonio P.
    BLOOD, 2009, 114 (22) : 1037 - 1038
  • [27] Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome
    Egan-Sherry, Dana
    Bhuta, Roma
    Cole, Peter D.
    Gennarini, Lisa M.
    Kahn, Justine M.
    Sulis, Maria Luisa
    DeNardo, Bradley D.
    Welch, Jennifer J. G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E997 - E999
  • [28] Increased phosphorylation of arabinofuranosyl cytosine by cyclopentenyl cytosine in pediatric acute lymphocytic leukemia.
    Verschuur, AC
    Van Gennip, AH
    Leen, R
    Voûte, PA
    Van Kuilenburg, ABP
    BLOOD, 2001, 98 (11) : 182B - 182B
  • [29] Development of a Novel Treatment Strategy Targeting JAK2 in Acute Myelogenous Leukemia.
    Kojima, Shinsuke
    Ikezoe, Takayuki
    Yang, Jing
    Nshioka, Chie
    Takeuchi, Asako
    Isaka, Mayuka
    Furihata, Mutsuo
    Yokoyama, Akihito
    BLOOD, 2009, 114 (22) : 1027 - 1027
  • [30] Successful treatment of Aspergillus spondylodiscitis with high-dose itraconazole in a patient with acute myelogenous leukemia
    Takagi, K
    Yoshida, A
    Yamauchi, T
    Yamashita, T
    Iwasaki, H
    Tsutani, H
    Maezawa, Y
    Baba, H
    Ueda, T
    LEUKEMIA, 2001, 15 (10) : 1670 - 1671
12345